Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations

Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations

(1) Background: In literature, approximately 20% of mCRPC present somatic DNA damage repair (DDR) gene mutations, and their relationship with response to standard therapies in mCRPC is not well understood. The objective was to evaluate outcomes of mCRPC patients treated with standard therapies accor...

Full description

Bibliographic Details
Main Authors: Bonnet, I. (Author), Boulouard, F. (Author), Brachet, P.-E (Author), Castéra, L. (Author), Coquan, E. (Author), Joly, F. (Author), Krieger, S. (Author), Leconte, A. (Author), Lelaidier, A. (Author), Lequesne, J. (Author), Meriaux, E. (Author), Neviere, Z. (Author), Ricou, A. (Author), Vaur, D. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
homologous repair
molecular profile
prostate cancer
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items